Tendyne™

Transcatheter Mitral Valve Implantation (TMVI)

Trifecta GT

Quality Time Secured.

Tendyne™ TMVI is first-in-class technology that offers patients with symptomatic, significant mitral regurgitation (grade >3) a minimally invasive treatment option for valve replacement.

  • Most patients (99%) achieve complete MR elimination at 30 days, with sustained MR elimination in the majority at 1 and 2 years1
  • Technical success rate of 96%1,*
  • Clinically significant improvement in symptom and quality-of-life measures1

*Technical success per MVARC.

 

Distinct Design for Device Control and Flexibility

  • Specifically designed for the challenging mitral anatomy
  • Contoured, dual-frame design easily conforms to mitral annulus, supporting a secure seal
  • Fully repositionable and retrievable intraprocedurally for optimal valve placement
  • Array of valve sizes to address a wide range of annular dimensions
 Illustration of the Tendyne mitral valve

Learn more about the Trifecta™ Valve with Glide™ Technology by visiting the Abbott Structural Heart website

Ordering Information

Valve Product Specifications

 

ModelValve NumberCatalog NumberDevice AP (mm)Device IC (mm)Device Perimeter (mm)EOA (cm2)
SP33STENDV-SP-33S32.543.51303.0
33MTENDV-SP-33M32.546.5136
33LTENDV-SP-33L32.550.5144
35MTENDV-SP-35M34.548.5144
37STENDV-SP-37S36.546.5144
37LTENDV-SP-37L36.552.5156
39MTENDV-SP-39M38.550.5156
41STENDV-SP-41S40.547.5154
LP29STENDV-LP-29S29.042.51192.2
29LTENDV-LP-29L29.047.5129
33STENDV-LP-33S32.543.5130
35MTENDV-LP-35M34.548.5144
37MTENDV-LP-37M36.549.5150


Implantation and Retrieval System Product Specifications

DescriptionCatalog NumberApproximate Dimensions (cm)
Tendyne™ Loading SystemTENDV-LS18 x 9 x 61
Tendyne™ Delivery System*TENDV-DS6.5 x 7.5 x 89
Tendyne™ Pad Position SystemTENDV-PS5 x 7.5 x 38
Tendyne™ Retrieval System*TENDV-RS18 x 10 x 76
Tendyne 2 Lb. WeightTENDV-WTN/A
Tendyne StandTENDV-STN/A
Tendyne Stand ComponentsTENDV-SCN/A
*Sheath ID for the delivery system and retrieval system is 36F.


References

1. Muller D, et al. Two-Year Outcomes of Tendyne Transcatheter Mitral Valve Implantation to Treat Symptomatic, Severe Mitral Regurgitation. Presented at PCR E-Course, June, 2020.

MAT-2002383 v3.0 | Item approved for Global OUS use only.